Clinical Trials Reimagined: How Technology Is Accelerating Research

Clinical trials have long been the slowest and most expensive stage of drug development, but a wave of technology-driven innovation is compressing timelines and expanding who can participate in the research process itself.

Trials Move Out of the Clinic

Decentralized clinical trials — which use telehealth visits, home health nurses, and local labs instead of requiring participants to travel repeatedly to a central trial site — are dramatically widening the pool of eligible participants, particularly for rural patients and those with mobility limitations who were previously effectively excluded from trial participation.

Wearables Provide Continuous Data

Wearable devices now continuously capture physiological data throughout a trial rather than only during periodic clinic visits, giving researchers a far richer picture of how a treatment is actually affecting patients day to day — and in some cases enabling earlier detection of adverse effects than infrequent clinic visits would catch.

AI Accelerates Patient Matching

Slow patient enrollment remains the single most common cause of clinical trial delay. AI systems that scan electronic health records to identify eligible candidates matching a trial's specific inclusion criteria are cutting enrollment timelines significantly compared to the manual chart review process trial coordinators have long relied on.